NCT04363697View on ClinicalTrials.gov

Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

PHASE4CompletedINTERVENTIONAL
Enrollment

2,401

Participants

Timeline

Start Date

September 24, 2020

Primary Completion Date

June 2, 2025

Study Completion Date

June 2, 2025

Conditions
Acute Heart FailureHeart Failure
Interventions
DRUG

Dapagliflozin

Dapagliflozin

DRUG

Placebo

Matched placebo

Trial Locations (1)

02115

TIMI Study Group, Boston

Sponsors
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Worldwide Clinical Trials

OTHER

lead

The TIMI Study Group

OTHER